RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Just as there has been some modest thawing in the overall credit market as the 'psychology' has shifted (somewhat, depending on who you listen to) regarding the economic downturn--and I have seen it directly in Big Pharma expenditures, which had been totally frozen for a few months--there is a thaw coming in licensing/M&A money. That thaw is not instantaneous, the process is still slower than it should be, and used to be. My point was that--IMHO--that company-specific statements were being made which overlooked the systemic factors.

Big and midsize Pharma money will flow before microcap financing money does, which is why the financing terms were so lousy.

NeuroInvestment